Sunday august 4th (sunday), the Confidentiality and Exclusivity clause ends between Poet and DenseLight's buyer.

I think it would be good risk management for Poet to look out for a Plan B (or C if a Plan B is already in place) if the current deal isn't progressing the way they had think.

There's some dates/milestones associated with Espresso Capital and they don't want to be caught shortsighted since Poet's assets are linked to the line of credit.

From the FAQ (NR released februaray 4th) :

#1. What can shareholders and others know about the contents of the LOI?

The Press Release has been approved by both sides and contains the key items that the Company

and the potential Buyer are prepared to disclose today, namely:

• Purchase of the capital stock of POET’s wholly-owned subsidiary.

• Total Consideration: US$30M cash, with $4 million in an “earn-out”.

• Inclusion of both a “Preferred Supplier Agreement” and “Strategic Cooperation

Agreement”, the details of which will be negotiated as part of the transaction.

• POET to retain ownership to all Intellectual Property unique to the Optical Interposer

• Six-month Confidentiality and Exclusivity (i.e. no discussion and no shop).

• Target date for completion is ON OR BEFORE September 15, 2019.